Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Moodys
Argus Health
US Army
Dow
Cantor Fitzgerald
Cipla
Healthtrust

Generated: October 16, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Alisertib

« Back to Dashboard

US Patents for Alisertib

Glossary
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Alisertib ➤ Try a Free Trial Aurora kinase inhibitors for inhibiting mitotic progression Millennium Pharmaceuticials, Inc. (Cambridge, MA) ➤ Try a Free Trial
Alisertib ➤ Try a Free Trial Crystalline forms of sodium 4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-D][2]benzazepin- -2-yl]amino}-2-methoxybenzoate Millennium Pharmaceuticals, Inc. (Cambridge, MA) ➤ Try a Free Trial
Alisertib ➤ Try a Free Trial Pharmaceutical compositions for the treatment of cancer and other diseases or disorders Millennium Pharmaceuticals, Inc. (Cambridge, MA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Alisertib

Glossary
Drugname Country Document Number Estimated Expiration Related US Patent
Alisertib Argentina 064246 2026-11-16 ➤ Try a Free Trial
Alisertib Austria 556076 2026-11-16 ➤ Try a Free Trial
Alisertib Australia 2007322046 2026-11-16 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
Teva
Medtronic
Argus Health
McKinsey
Federal Trade Commission
Chinese Patent Office
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: